Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (161-170 of 321) with videos related to

Pageof 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Age-dependent prognostic effects of genetic alterations in glioblastomaTracy T Batchelor, Rebecca A Betensky, J Matthew Esposito, et al.
Neuro-Oncology|January 8, 2017
Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture modelsJian Teng, Cintia C da Hora, Rami S Kantar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideStuart A Grossman, Kathryn A Carson, Tracy T Batchelor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2007
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelinesD D Correa, L Maron, H Harder, et al.
Nature Reviews. Clinical Oncology|April 1, 2009
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancerElizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Future Oncology (London, England)|June 19, 2026
IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphomaLakshmi Nayak, Christian Grommes, Charles Psoinos, et al.
Brain : a Journal of Neurology|March 2, 1999
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disordersJ Dalmau, S H Gultekin, R Voltz, et al.
AJNR. American Journal of Neuroradiology|June 13, 2015
Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed GlioblastomaM A Prah, S M Stufflebeam, E S Paulson, et al.
Cancer Research|December 1, 2011
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusionA Gregory Sorensen, Kyrre E Emblem, Pavlina Polaskova, et al.
Nature Reviews. Disease Primers|June 15, 2023
Primary central nervous system lymphomaAndrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, et al.
Pageof 33

Showing results (161-170 of 321) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Age-dependent prognostic effects of genetic alterations in glioblastomaTracy T Batchelor, Rebecca A Betensky, J Matthew Esposito, et al.
Neuro-Oncology|January 8, 2017
Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture modelsJian Teng, Cintia C da Hora, Rami S Kantar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideStuart A Grossman, Kathryn A Carson, Tracy T Batchelor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2007
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelinesD D Correa, L Maron, H Harder, et al.
Nature Reviews. Clinical Oncology|April 1, 2009
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancerElizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Future Oncology (London, England)|June 19, 2026
IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphomaLakshmi Nayak, Christian Grommes, Charles Psoinos, et al.
Brain : a Journal of Neurology|March 2, 1999
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disordersJ Dalmau, S H Gultekin, R Voltz, et al.
AJNR. American Journal of Neuroradiology|June 13, 2015
Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed GlioblastomaM A Prah, S M Stufflebeam, E S Paulson, et al.
Cancer Research|December 1, 2011
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusionA Gregory Sorensen, Kyrre E Emblem, Pavlina Polaskova, et al.
Nature Reviews. Disease Primers|June 15, 2023
Primary central nervous system lymphomaAndrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, et al.
Pageof 33